Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 24,576 | 20,218 | 23,320 | 22,100 | 25,411 |
| Cost of Goods | 20,225 | 17,941 | 18,928 | 17,989 | 19,924 |
| Gross Profit | 4,351 | 2,276 | 4,392 | 4,112 | 5,487 |
| Operating Expenses | 2,079 | 1,416 | 1,693 | 1,666 | 1,536 |
| Operating Income | 2,272 | 860 | 2,699 | 2,446 | 3,951 |
| Other Income | -865 | -51 | 107 | -96 | -733 |
| Pre-tax Income | 1,407 | 809 | 2,807 | 2,350 | 3,218 |
| Income Tax | 412 | 157 | 495 | 793 | 1,131 |
| Net Income Continuous | 995 | 652 | 2,312 | 1,557 | 2,087 |
| Net Income | $995 | $652 | $2,312 | $1,557 | $2,087 |
| EPS Basic Total Ops | 0.04 | 0.03 | 0.09 | 0.07 | 0.09 |
| EPS Basic Continuous Ops | 0.04 | 0.03 | 0.09 | 0.07 | 0.09 |
| EPS Diluted Total Ops | 0.04 | 0.03 | 0.09 | 0.07 | 0.09 |
| EPS Diluted Continuous Ops | 0.04 | 0.03 | 0.09 | 0.07 | 0.09 |
| EBITDA(a) | $4,367 | $2,276 | $4,392 | $4,339 | $5,611 |